These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 6100289

  • 1. Etiology of hepatocellular carcinoma in Africa.
    Olweny CL.
    IARC Sci Publ; 1984; (63):89-95. PubMed ID: 6100289
    [Abstract] [Full Text] [Related]

  • 2. [Hepatocellular carcinoma, hepatitis B virus and the immune system].
    Grob PJ.
    Schweiz Med Wochenschr; 1986 Aug 23; 116(34):1133-45. PubMed ID: 3020684
    [Abstract] [Full Text] [Related]

  • 3. Does hepatitis B virus cause hepatocellular carcinoma?
    Trichopoulos D, Kremastinou J, Tzonou A.
    IARC Sci Publ; 1982 Aug 23; (39):317-32. PubMed ID: 6295934
    [Abstract] [Full Text] [Related]

  • 4. Synergism between hepatitis B virus and aflatoxin in hepatocellular carcinoma.
    Ayoola EA.
    IARC Sci Publ; 1984 Aug 23; (63):167-79. PubMed ID: 6100268
    [Abstract] [Full Text] [Related]

  • 5. Hepatitis B virus and the control of hepatocellular carcinoma.
    Blumberg BS.
    IARC Sci Publ; 1984 Aug 23; (63):243-61. PubMed ID: 6100273
    [Abstract] [Full Text] [Related]

  • 6. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
    Shrestha SM, Shrestha S, Shrestha A, Tsuda F, Endo K, Takahashi M, Okamoto H.
    J Gastroenterol Hepatol; 2007 Nov 23; 22(11):1921-8. PubMed ID: 17914971
    [Abstract] [Full Text] [Related]

  • 7. Hepatocellular carcinoma in the U.S.A., etiologic considerations. Localization of hepatitis B antigens.
    Omata M, Ashcavai M, Liew CT, Peters RL.
    Gastroenterology; 1979 Feb 23; 76(2):279-87. PubMed ID: 215488
    [Abstract] [Full Text] [Related]

  • 8. Presence of antibodies to the hepatitis B surface antigen is associated with an excess risk for hepatocellular carcinoma among non-Asians in Los Angeles County, California.
    Yu MC, Yuan JM, Ross RK, Govindarajan S.
    Hepatology; 1997 Jan 23; 25(1):226-8. PubMed ID: 8985295
    [Abstract] [Full Text] [Related]

  • 9. Hepatocellular carcinoma and infections with multiple hepatitis viruses.
    Brunetto MR, Oliveri F, Colombatto P, Bonino F.
    Princess Takamatsu Symp; 1995 Jan 23; 25():61-6. PubMed ID: 8875610
    [Abstract] [Full Text] [Related]

  • 10. Hepatitis B virus chronic liver disease and hepatocellular carcinoma.
    Zuckerman AJ, Harrison TJ.
    Postgrad Med J; 1987 Jan 23; 63 Suppl 2(737):13-9. PubMed ID: 2825153
    [Abstract] [Full Text] [Related]

  • 11. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG, Mathews S, Jayanthi V, Shankar EM, Hari R, Surendran R, Vengatesan A, Raghuram K, Rajasambandam P, Murali A, Srinivas U, Palaniswamy KR, Pugazhendhi T, Thyagarajan SP.
    Int J Infect Dis; 2008 Nov 23; 12(6):e71-6. PubMed ID: 18658001
    [Abstract] [Full Text] [Related]

  • 12. 249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma.
    Kirk GD, Lesi OA, Mendy M, Szymañska K, Whittle H, Goedert JJ, Hainaut P, Montesano R.
    Oncogene; 2005 Sep 01; 24(38):5858-67. PubMed ID: 16007211
    [Abstract] [Full Text] [Related]

  • 13. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S, Nakashima Y, Kojiro M, Tabor E.
    J Viral Hepat; 2005 May 01; 12(3):325-9. PubMed ID: 15850475
    [Abstract] [Full Text] [Related]

  • 14. Possible contribution of prior hepatitis B virus infection to the development of hepatocellular carcinoma.
    Tanaka H, Iwasaki Y, Nouso K, Kobayashi Y, Nakamura S, Matsumoto E, Toshikuni N, Kaneyoshi T, Ohsawa T, Takaguchi K, Fujio K, Senoh T, Ohnishi T, Sakaguchi K, Shiratori Y.
    J Gastroenterol Hepatol; 2005 Jun 01; 20(6):850-6. PubMed ID: 15946131
    [Abstract] [Full Text] [Related]

  • 15. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M, Kumar R, Hissar SS, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK.
    J Gastroenterol Hepatol; 2007 Jul 01; 22(7):1104-11. PubMed ID: 17559381
    [Abstract] [Full Text] [Related]

  • 16. [Epidemiology of hepatocellular carcinoma].
    Ricca Rosellini S, Miglio F.
    Minerva Gastroenterol Dietol; 1991 Jul 01; 37(2):73-84. PubMed ID: 1660311
    [Abstract] [Full Text] [Related]

  • 17. Prospects for epidemiological studies on hepatocellular cancer as a model for assessing viral and chemical interactions.
    Bosch FX, Muñoz N.
    IARC Sci Publ; 1988 Jul 01; (89):427-38. PubMed ID: 2848766
    [Abstract] [Full Text] [Related]

  • 18. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients.
    Squadrito G, Pollicino T, Cacciola I, Caccamo G, Villari D, La Masa T, Restuccia T, Cucinotta E, Scisca C, Magazzu D, Raimondo G.
    Cancer; 2006 Mar 15; 106(6):1326-30. PubMed ID: 16453330
    [Abstract] [Full Text] [Related]

  • 19. Relation between hepatocellular carcinoma and persistent hepatitis B infection.
    Popper H.
    Appl Pathol; 1988 Mar 15; 6(2):64-72. PubMed ID: 2839217
    [Abstract] [Full Text] [Related]

  • 20. [Hepatocellular carcinoma: a preventable cancer].
    Viviani S, Jack A, Bah E, Montesano R.
    Epidemiol Prev; 1997 Mar 15; 21(2):129-36. PubMed ID: 9378180
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.